Archives of Clinical Ophthalmology

Commentary Open Access

Generating Awareness and a Planned Multidisciplinary Treatment Approach Can Save Both the Sight and Life in Retinoblastoma in Developing Countries

Soma Rani Roy

While rare, retinoblastoma is the most common (1:16000 – 18000 live births) intraocular and life threatening tumor of childhood [1,2]. According to the World Health Organization (WHO), 66% of children present with symptoms before 2 years of age and 95% before 5 years of age. About 8000 new cases are detected annually with the highest incidence in Africa and India. In fact, more than 1400 cases each year are from India [3].

Arch Clin Ophthalmol, 2021, Volume 1, Issue 1, p27-29 | DOI: 10.33696/Ophthalmology.1.005

Commentary Open Access

Multidisciplinary Acute Care of Central Retinal Artery Occlusion with a Stroke Paradigm: A Call to Action

Stacey Q. Wolfe , Stephanie A. Coffman , Mark Perez , Katriel Lee , Bartlett H.Hayes , Tamra Ranasinghe , Patrick A. Brown , Kyle M. Fargen

Central retinal artery occlusion (CRAO) is a painless ophthalmologic emergency with potential for irreversible vision loss. Similar to ischemic stroke, CRAO occurs when there is sudden obstruction of the central retinal artery, leading to ischemic injury to the retina and subsequent cell death. Continuous occlusion and ischemia of the retina progresses to permanent damage to retinal cells and loss of vision.

Arch Clin Ophthalmol, 2021, Volume 1, Issue 1, p20-26 | DOI: 10.33696/Ophthalmology.1.004

Editorial Open Access

Mega-Dose Dietary Riboflavin in Treatment in Keratoconus, Post-Refractive Cornea Ectasia and Migraine. Has Its Time Arrived?

John Steven Jarstad

Recently, several studies and investigators have shown the beneficial effects of high dose dietary riboflavin (vitamin B2) in the treatment of keratoconus, post-refractive (LASIK, PRK & Radial Keratotomy) ectasia (with sunlight exposure) and patients treated with our own protocol (NIH Clinical Study – www.clinicaltrials.gov - # NCT 03095235) discovered significant relief for intractable migraine headaches and/or ophthalmic migraine (classic migraine visual symptoms without headache).

Arch Clin Ophthalmol, 2021, Volume 1, Issue 1, p20-20 | DOI: 10.33696/Ophthalmology.1.003